AstraZeneca Pharma India Limited — Others, 09-12-2024: Certificate under SEBI (Depositories and Participants) Regulations, 2018

AstraZeneca Pharma India Limited has submitted a compliance certificate to the stock exchanges, confirming adherence to the relevant SEBI regulations for the dematerialization of securities for the period from November 1 to November 30, 2024. This includes confirmation that the securities are listed on applicable exchanges and proper handling of mutilated certificates.

This update reflects the company's commitment to maintaining regulatory compliance and efficient operations in share management. For investors, this demonstrates operational transparency and regulatory adherence, contributing to a positive outlook while reinforcing confidence in the company’s governance practices.